Published in Antimicrob Agents Chemother on May 29, 2012
Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups. Antimicrob Agents Chemother (2013) 1.98
Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance. Antimicrob Agents Chemother (2013) 1.35
Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother (2013) 1.14
Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist (2012) 1.10
KPC - 3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients. BMC Anesthesiol (2013) 1.03
Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35. Antimicrob Agents Chemother (2014) 0.92
Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to β-lactam antibiotics. Antimicrob Agents Chemother (2015) 0.88
IS5 element integration, a novel mechanism for rapid in vivo emergence of tigecycline nonsusceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother (2014) 0.84
Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method. J Clin Microbiol (2014) 0.83
The Resistance Mechanism and Clonal Distribution of Tigecycline-Nonsusceptible Klebsiella pneumoniae Isolates in Korea. Yonsei Med J (2016) 0.79
Mutant prevention concentration of tigecycline for clinical isolates of Streptococcus pneumoniae and Staphylococcus aureus. J Antimicrob Chemother (2014) 0.76
Decreased Susceptibility to Tigecycline Mediated by a Mutation in mlaA in Escherichia coli Strains. Antimicrob Agents Chemother (2016) 0.75
Burden of extensively drug-resistant and pandrug-resistant Gram-negative bacteria at a tertiary-care centre. New Microbes New Infect (2015) 0.75
Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin Infect Dis (2008) 3.56
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob Agents Chemother (2009) 3.09
Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother (2005) 2.22
Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis (2009) 2.19
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother (2006) 1.99
Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother (2003) 1.97
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents (2011) 1.89
The pharmacokinetic and pharmacodynamic profile of tigecycline. Clin Infect Dis (2005) 1.68
RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microb Drug Resist (2007) 1.66
Rapid development of Acinetobacter baumannii resistance to tigecycline. Pharmacotherapy (2007) 1.50
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother (2009) 1.40
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]. BMC Infect Dis (2005) 1.40
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. Antimicrob Agents Chemother (2005) 1.38
A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline. J Antimicrob Chemother (2009) 1.37
Evaluation of the DiversiLab system for detection of hospital outbreaks of infections by different bacterial species. J Clin Microbiol (2010) 1.36
Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae. Pharmacotherapy (2007) 1.26
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial. Int J Infect Dis (2005) 1.22
Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii. Pharmacotherapy (2007) 1.21
Tigecycline pharmacokinetic/pharmacodynamic update. J Antimicrob Chemother (2008) 1.16
Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective. J Clin Microbiol (2008) 1.14
Real-time PCR and statistical analyses of acrAB and ramA expression in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother (2008) 1.13
Tigecycline: a glycylcycline antimicrobial agent. Clin Ther (2006) 1.13
Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J Antimicrob Chemother (2008) 1.11
Validation and reproducibility assessment of tigecycline MIC determinations by Etest. J Clin Microbiol (2007) 1.09
Escherichia coli variants in periprosthetic joint infection: diagnostic challenges with sessile bacteria and sonication. J Clin Microbiol (2010) 1.09
First case of resistance to tigecycline by Klebsiella pneumoniae in a European University Hospital. Indian J Med Microbiol (2011) 1.03
Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis. J Antimicrob Chemother (2011) 1.03
Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient. Ann Saudi Med (2010) 1.00
Single daily high-dose tigecycline therapy of a multidrug-resistant (MDR) Klebsiella pneumoniae and Enterobacter aerogenes nosocomial urinary tract infection. J Chemother (2007) 0.97
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Clin Microbiol Infect (2011) 0.96
Application of minimal sequence quality values prevents misidentification of the blaSHV type in single bacterial isolates carrying different SHV extended-spectrum beta-lactamase genes. J Clin Microbiol (2006) 0.87
Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy. Antimicrob Agents Chemother (2009) 0.79
Prosthetic joint infection: recent developments in diagnosis and management. J Infect (2010) 4.96
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother (2007) 2.97
Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents (2007) 2.61
Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother (2007) 1.91
Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. J Antimicrob Chemother (2006) 1.88
Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario. AIDS (2003) 1.77
High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes (2010) 1.74
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med (2013) 1.74
Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. Surgery (2002) 1.65
Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J Clin Microbiol (2011) 1.58
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med (2015) 1.54
Recurrent ventriculoperitoneal shunt infection caused by small-colony variants of Staphylococcus aureus. Clin Infect Dis (2005) 1.53
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother (2009) 1.40
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med (2008) 1.38
Use of the VITEK 2 system for rapid identification of clinical isolates of Staphylococci from bloodstream infections. J Clin Microbiol (2003) 1.36
Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis (2009) 1.28
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother (2008) 1.27
Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am J Med (2006) 1.25
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology (2003) 1.23
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis (2004) 1.18
Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother (2011) 1.18
Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation. Ann Thorac Surg (2004) 1.15
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology. Emerg Infect Dis (2002) 1.12
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother (2002) 1.09
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates. J Clin Microbiol (2006) 1.07
Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy. AIDS (2003) 1.04
Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC). J Clin Microbiol (2012) 1.02
Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. J Antimicrob Chemother (2012) 1.02
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. J Antimicrob Chemother (2014) 1.02
Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. Int J Antimicrob Agents (2010) 1.01
Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and management. Curr Opin Pulm Med (2009) 1.01
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment. Intensive Care Med (2008) 0.98
Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation. Cardiovasc Diabetol (2009) 0.98
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes. Antimicrob Agents Chemother (2012) 0.96
Identification of methicillin-resistant isolates of Staphylococcus aureus and coagulase-negative staphylococci responsible for bloodstream infections with the Phoenix system. Diagn Microbiol Infect Dis (2004) 0.96
Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa. J Acquir Immune Defic Syndr (2012) 0.92
CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow. Blood (2011) 0.91
Aggressive versus conservative initiation of antibiotics. Lancet Infect Dis (2013) 0.89
Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. J Infect Dis (2002) 0.87
Molecular identification of Leuconostoc mesenteroides as a cause of brain abscess in an immunocompromised patient. J Clin Microbiol (2006) 0.87
Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model. Infect Control Hosp Epidemiol (2012) 0.87
The importance of addressing multidrug resistance and not assuming single-drug resistance in case-control studies. Infect Control Hosp Epidemiol (2006) 0.86
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma. AIDS (2010) 0.86
Risk scoring and bloodstream infections. Int J Antimicrob Agents (2007) 0.84
Agreement among healthcare professionals in ten European countries in diagnosing case-vignettes of surgical-site infections. PLoS One (2013) 0.84
Fungal infections in immunocompromised patients. Mycoses (2011) 0.83
Infections and organ transplantation: new challenges for prevention and treatment--a colloquium. Transplantation (2012) 0.82
Radiology quiz case 2. Lobular capillary hemangioma (LCH). Arch Otolaryngol Head Neck Surg (2010) 0.82
Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility. FEMS Immunol Med Microbiol (2004) 0.82
The complimentary role of diagnostic and therapeutic endoscopy in foreign body aspiration in children. Int J Pediatr Otorhinolaryngol (2011) 0.82
The TREAT project: decision support and prediction using causal probabilistic networks. Int J Antimicrob Agents (2007) 0.81
Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial options. Int J Antimicrob Agents (2011) 0.81
Clinical course and long-term outcome of hantavirus-associated nephropathia epidemica, Germany. Emerg Infect Dis (2015) 0.80
Participation of elderly adults in randomized controlled trials addressing antibiotic treatment of pneumonia. J Am Geriatr Soc (2015) 0.80
How could we reduce antibiotic use in critically ill patients? Infect Disord Drug Targets (2011) 0.79
Spectrum of sepsis, mediators, source control and management of bundles. Front Biosci (Elite Ed) (2010) 0.79
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother (2008) 0.79
Prediction of specific pathogens in patients with sepsis: evaluation of TREAT, a computerized decision support system. J Antimicrob Chemother (2007) 0.79
Deep neck infection complicating lymphadenitis caused by Streptococcus intermedius in an immunocompetent child. BMC Infect Dis (2006) 0.79
Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis. Int J Antimicrob Agents (2012) 0.79
Prediction of bacteremia using TREAT, a computerized decision-support system. Clin Infect Dis (2006) 0.78
Yellow nails, ankle edema, and pleural effusion. Cleve Clin J Med (2009) 0.78
Sphingosine 1-phosphate promotes antigen processing and presentation to CD4+ T cells in Mycobacterium tuberculosis-infected monocytes. Biochem Biophys Res Commun (2007) 0.78
Ventriculitis due to Staphylococcus lugdunensis: two case reports. J Med Case Rep (2008) 0.78
Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study. BMC Infect Dis (2012) 0.77
Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010. Clin Infect Dis (2011) 0.77
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association. Jpn J Radiol (2013) 0.77
[Diagnosis of intra-abdominal infections: clinical findings and imaging]. Infez Med (2008) 0.77
Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections. Int J Infect Dis (2010) 0.76
Fighting antibiotic resistance all over Europe. Expert Rev Anti Infect Ther (2010) 0.76
Recurrent venous thrombosis in a patient with haemophilia A and HIV infection. Haematologica (2002) 0.76
Impact of availability of guidelines and active surveillance in reducing the incidence of ventilator-associated pneumonia in Europe and worldwide. BMC Infect Dis (2014) 0.75
Vancomycin Way of Administration: Where is the Evidence? Clin Infect Dis (2011) 0.75
Do not tell the children: toothbrushing does not make a difference (in your ventilator-associated pneumonia rates). Crit Care Med (2013) 0.75
Screening of multidrug-resistant bacteria in high-risk patients: an ongoing discussion. Crit Care Med (2011) 0.75
Unnecessary perioperative antibiotic prophylaxis in the placement of totally implanted central venous access ports should be avoided. Am J Surg (2011) 0.75
Endoscopic surgery for recurrent undifferentiated nasopharyngeal carcinoma. J Craniofac Surg (2014) 0.75
Sinonasal polyposis in the elderly. Am J Rhinol Allergy (2016) 0.75
Endoscopic treatment of tracheocele in pediatric patients. Am J Otolaryngol (2009) 0.75
[Treatment of pancreatic necrosis and secondary pancreatic infections]. Chir Ital (2002) 0.75
Treatment options for community-acquired pneumonia in the elderly people. Expert Rev Anti Infect Ther (2015) 0.75
Impact of antibiotic stewardship on perioperative antimicrobial prophylaxis. Int J Qual Health Care (2016) 0.75
Penetrating foreign body mimicking supraglottic carcinoma. Ann Otol Rhinol Laryngol (2005) 0.75
Tension-free inguinal hernia repair in "one-day surgery". Experience of 1091 cases. Hepatogastroenterology (2002) 0.75
[Intra-abdominal infections: definitions and classification]. Infez Med (2008) 0.75
Comparison of Mycoplasma IES, Mycofast Revolution and Mycoplasma IST2 to detect genital mycoplasmas in clinical samples. J Infect Dev Ctries (2017) 0.75
Antimicrobial prevention and therapy for travelers' infection. Expert Rev Anti Infect Ther (2007) 0.75